Research Project's efficient solution for early cancer detection receives Leonardo da Vinci Prize

International philanthropists are challenging the world to provide a Cancer Research Project offering the most efficient solution in Particle Physics for early cancer detection with the highest potential to reduce premature cancer death.

Challengers who would like to join this effort can contribute to:

Bank account for the Leonardo da Vinci Prize:
FROST BANK (Dallas)
cc. 960022454, ABA 114000093, SWIFT FRSTUS44

Important Dates:
Rule change deadline, January 31, 2011
Submission of projects, February 1, March 15, 2011
Revision of projects, March 22, 2011
Prize award, April 5, 2011

Media Coverage
Scrutiny of the projects will be made public live from the University of Pavia (Italy).

This is a request for comments regarding proposed rules of the Leonardo da Vinci Prize for reduction of premature cancer death which aim to 1) ensure that judgment for the best project is a result of logical reasoning, sound calculations and scientific merit and 2) eliminate the possibility of favoritisms that do not comply with this goal.

Experimental data (published by WHO, reported on April 24, 2009 in The New York Times) demonstrates that over the past 50 years, reduction in cancer death has been recorded as a mere 5%, while for heart disease for the same period the reduction was 64%, for stroke 74%, and influenza and pneumonia 58%. Cancer is costing you over $750 per year per capita. Direct medical expenditures related to cancer have increased to approximately 100 times that of 50 years ago, while the cost of primary food in the U.S. for the same period has increased only 4 times. Data also show that early diagnosis has the probability to save lives in 90% to 98% of cases.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI models redefine TIL scoring in breast cancer but face challenges in real-world validation